More bad news for the blood-testing startup with the $9 billion valuation. The results of Theranos’s cholesterol tests varied enough from those done by the country’s two biggest lab companies (Quest Diagnostics and Laboratory Corp. of America) that “they could throw off doctors’ medical decisions,” reports the Wall Street Journal. The study, published Monday in the Journal of Clinical Investigations, found that the “results for total cholesterol were lower by an average of 9.3% than those produced by Quest and LabCorp.”
collections
NewsletterCourses and LearningAdvertiseCurrent IssueFast Government
The future of innovation and technology in government for the greater good
Most Innovative Companies
Fast Company's annual ranking of businesses that are making an outsize impact
Most Creative People
Leaders who are shaping the future of business in creative ways
World Changing Ideas
New workplaces, new food sources, new medicine--even an entirely new economic system
Innovation By Design
Celebrating the best ideas in business